Soligenix Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 0/6
Wichtige Informationen
389.9%
Verhältnis von Schulden zu Eigenkapital
US$3.00m
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | US$7.09m |
| Eigenkapital | US$768.37k |
| Gesamtverbindlichkeiten | US$7.29m |
| Gesamtvermögen | US$8.06m |
Jüngste Berichte zur Finanzlage
Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Sep 06
Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Apr 22Is Soligenix (NASDAQ:SNGX) Using Too Much Debt?
Jan 03Recent updates
Soligenix: A Biotech Bargain Ready To File For Approval In Cutaneous T-Cell Lymphoma
Oct 05U.S. FDA awards $2.6M grant for expanded study of Soligenix's HyBryte for skin cancer
Sep 12Soligenix announces $2.6M FDA grant to further study blood cancer candidate
Sep 06Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Sep 06Soligenix GAAP EPS of -$0.06 beats by $0.03, revenue of $0.4M beats by $0.2M
Aug 12Soligenix, SERB Pharma team up to develop therapy for ricin poisoning
Jul 25Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Apr 22Is Soligenix (NASDAQ:SNGX) Using Too Much Debt?
Jan 03Shareholders May Find It Hard To Justify Increasing Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation For Now
Sep 17Health Check: How Prudently Does Soligenix (NASDAQ:SNGX) Use Debt?
Aug 30Is Soligenix (NASDAQ:SNGX) Weighed On By Its Debt Load?
May 08What Type Of Returns Would Soligenix's(NASDAQ:SNGX) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Mar 16